Pricing Log in Create free account

Biomea Fusion, Inc. (BMEA) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

Biomea Fusion, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. Biomea Fusion, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($44.8M and $42.6M). Across the 8 metrics below, Mereo BioPharma Group plc - Sponsored ADR leads on 6 and Biomea Fusion, Inc. on 2.

Valuation

Metric BMEA MREO Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 3.34 1.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (88.54%) (62.36%) (32.88%)
Free cash flow yield (115.76%) (57.04%) (23.13%)

Profitability

Metric BMEA MREO Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (164.14%) (67.85%) (51.96%)
Return on assets (59.14%) (57.73%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BMEA MREO Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 69.19% 10.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BMEA MREO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.48 5.88 4.97
Net debt to EBITDA 0.68 1.04 1.01

Dividend

Metric BMEA MREO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BMEA MREO Biotechnology median
Market cap 42.57m 44.76m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack